Click below to hear recorded Q&A audio for each question from our live webcast audience.

If an IGRA tests positive in someone who is immunocompromised, what are the next steps?

What next, if the QuantiFERON®-TB Gold/Plus was indeterminate in a 19-year-old with no risk factor? The screening for TB was necessary for adoption process. Should a T-SPOT®.TB test be ordered?

In foreign-born who have had BCG, do you recommend IGRAs across the board, or just for those who are immunocompromised?

What are the advantages of IGRA over TST when screening healthcare workers for latent TB?

Out of all of the examples of immunocompromised patients, should all of these types of immunocompromised patients be screened for TB, or only in certain situations?

Should someone who is PPD-positive be tested annually via QuantiFERON Gold or T-SPOT.TB test?

With regards to latent TB, specifically those with BCG vaccine, what are the repercussions? Or are there any?

You covered many examples of immunocompromised patients. Should all people identified with these risk factors be screened for TB, or just in certain situations?

T-SPOT is a registered trademark of Oxford Immunotec Ltd.
QuantiFERON is a registered trademark of the QIAGEN Group

About our Speaker

Avatar photo

Roy F. Chemaly, MD, MPH, FIDSA, FACP

Dr. Chemaly is a Professor of Medicine in the Department of Infectious Diseases, Infection Control & Employee Health at The University of Texas MD Anderson Cancer Center in Houston, Texas. Dr. Chemaly is the Director of the Infection Control and the Antimicrobial Stewardship programs at MD Anderson Cancer Center. He heads the Viral Protection Ad Hoc Infection Control Subcommittee, and serves as Director of the Clinical Virology Research Program in the Department of Infectious Diseases.

Thank you for watching this on-demand webinar.


Oxford Immunotec is committed to providing medical education on an on-going basis.

If you have a suggested topic of interest please email:

Welcome to Oxford Immunotec Medical Education

This website is intended to provide healthcare professionals and non-HCP researchers ONLY with medical education, resources and information on current clinical topics related to diagnosis and management of immune related conditions. This website is a resource for US healthcare professionals and non-HCP researchers. The information provided is for educational purposes only and is not intended to promote any products.

Are you a healthcare provider or researcher?

Yes No

If you are an employee of Oxford Immunotec with interest in viewing medical educational content, click here.

Leaving Oxford Immunotec Medical Education

You are now leaving the website of Oxford Immunotec Medical Education. External links are being provided as a convenience and for informational purposes only; they do not constitute an endorsement or an approval by Oxford Immunotec Medical Education of any of the products, services or opinions of the corporation or organization or individual. Oxford Immunotec Medical Education bears no responsibility for the accuracy, legality or content of the external site or for that of subsequent links.
Contact the external site for answers to questions regarding its content.

Are you sure you want to visit ?

Yes No